Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

Rapid Micro Biosystems signs $6.7M vaccine testing deal

September 22, 2010 6:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Rapid Micro Biosystems Inc. has signed a deal with the Biomedical Advanced Research and Development Authority that could net up to $6.7 million for the Bedford-based microbial contamination detection firm.

Elsevier Launches International Journal of Surgery Case Reports

September 22, 2010 6:34 am | by Bio-Medicine.Org | News | Comments

Elsevier Launches International Journal of Surgery Case Reports -- OXFORD, England, September 22, 2010 /-

TOPICS:

Endo Pharmaceuticals Receives FDA Priority Review for New Formulation of Long-Acting Oxymorphone Designed to be Crush Resistant

September 22, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

CHADDS FORD, Pa., Sept. 22 /- Endo Pharmaceuticals (Nasdaq: ENDP ) announced that it recently received notification from the U.S. Food and Drug Administration (FDA) that Endo's new drug application (NDA) for its new oral formulation of long-acting oxymorphone, which is designed to be...

TOPICS:
Advertisement

Precyse Solutions and M*Modal Announce Breakthrough CAC Solution

September 22, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

PITTSBURGH and WAYNE, Pa., Sept. 22 /- At the 82nd AHIMA Convention and Exhibit, Precyse Solutions , a leader in Health Information Management (HIM) services and technologies, and M*Modal , a pioneer of advanced Speech Understanding technology and provider of on-demand conversational...

TOPICS:

Neogen Corporation Announces 1st Quarter Results Conference Call

September 22, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

LANSING, Mich., Sept. 16 /- Neogen Corporation (Nasdaq: NEOG ) announces the following Webcast:What: Neogen Corporation 1st Quarter Results WebcastWhen: Thursday, September 23, 2010  @ 11:00 ETWhere: http://www.videonewswire.com/event.asp?id=72328 How: Live over the Internet --...

TOPICS:

Molecular Detection and Integrated Sciences Announce Distribution Agreement for Detect-Ready™ MRSA Assay in Australia

September 22, 2010 6:33 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa. and SYDNEY, Sept. 22 /- Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Integrated Sciences Pty. Ltd. today announced that they have entered into an exclusive...

TOPICS:

Amgen and Pfizer Introduce 'Psophisticated Style: A Guide to Everyday Style and Psoriasis™' Hosted by Tim Gunn

September 22, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 22 /- Amgen and Pfizer today announced the launch of "Psophisticated Style:  A Guide to Everyday Style and Psoriasis™," an online resource, providing a wealth of style advice specifically for people with psoriasis. Hosted by Tim Gunn, mentor to the designers on...

TOPICS:

Syndax Pharmaceuticals to Present at Sachs Biotech in Europe Investor Forum

September 22, 2010 6:32 am | by Bio-Medicine.Org | News | Comments

WALTHAM, Mass., Sept. 22 /- Syndax Pharmaceuticals, Inc., a clinical-stage epigenetics oncology company, today announced that Joanna Horobin, M.D., the company's president and CEO, will present at the Sachs Biotech in Europe Investor Forum Wednesday, September 29, 2010 at the Radisson Blu...

TOPICS:
Advertisement

Federal Register: Agency Information Collection Activities; Proposed Collection; Comment Request; Medical Devices Third-Party Review Under the Food and Drug Administration Mod...

September 22, 2010 6:30 am | by U.S. Food & Drug Administration | News | Comments

The FDA is announcing an opportunity for public comment on the proposed collection of certain information by the agency.

TOPICS:

Poster Highlights First Randomized Controlled Trial Comparing Market Leading Kinetic Concepts, Inc. Wound V.A.C.(R) System to Spiracur(R) SNaP(R) Wound Care System for Treatment of...

September 22, 2010 5:45 am | by The Associated Press | News | Comments

Leading wound care experts will present a Poster highlighting results from a multicenter randomized controlled trial (RCT) comparing negative pressure wound therapy (NPWT) between the SNaP@ Wound Care System from Spiracur, Inc., of Sunnyvale, Calif., and the Wound V.A.C.@ Therapy System...

TOPICS:

Dr. Brian Boxer Wachler to be Honored With Olympic Gold Medal Bobsled Champion Steve Holcomb Alongside Apple CEO Steve Jobs, James Cameron, Dan Rather, Quincy Jones and Others...

September 22, 2010 5:31 am | by Bio-Medicine.Org | News | Comments

BEVERLY HILLS, Calif., Sept. 22 /- After ten years of dedication to developing new, innovative treatments to help patients with Keratoconus, a degenerative eye disease that affects millions of people worldwide and can cause severe loss of vision, Dr. Brian S. Boxer Wachler, MD is to...

TOPICS:

Biomatrica Launches DNAgard® Blood and DNAstable Blood for Stabilization, Storage and Shipping of Whole Blood at Room Temperature

September 22, 2010 4:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, Sept. 22 /- Biomatrica Inc., the leader in room temperature biological sample stabilization, today announced the release of DNAgard® Blood and DNAstable® Blood. DNAgard® Blood is a new addition to the "Gard" product line for the stabilization and shipping of...

TOPICS:

Aeras and Crucell announce Phase II clinical trial start in Kenya

September 22, 2010 12:31 am | by EurekAlert | News | Comments

(Aeras Global TB Vaccine Foundation) Aeras and Crucell announce the start of a Phase II clinical trial in infants of the jointly developed TB vaccine candidate, AERAS-402/Crucell Ad35. The trial will test the safety and efficacy of the TB vaccine candidate in infants previously vaccinated...

TOPICS:

Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder

September 21, 2010 11:32 pm | by Bio-Medicine.Org | News | Comments

EAST HANOVER, N.J., Sept. 22 /- Novartis Pharmaceuticals Corporation ("Novartis") (NYSE: NVS ) announced today that the results of a Phase III study of SOM230 (pasireotide) showed a reduction in cortisol levels in patients with Cushing's disease, a condition in which a benign...

TOPICS:

NIH celebrates 10 years of research into health disparities

September 21, 2010 1:32 pm | by EurekAlert | News | Comments

(NIH/National Heart, Lung and Blood Institute) The tenth anniversary of the Jackson Heart Study (JHS) will be observed on Sept. 23-24 in Jackson, Mississippi. The JHS is the largest study in history to investigate genetic factors that affect high blood pressure, heart and lung disease,...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading